Position in OMER
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$6,002,578
-$4,333,648 QoQ
Shares Held
568,426
-5.5% QoQ
Ownership
0.785%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.06214705168307.ToString("F0")%
Shared 0.ToString("F0")%
None 0.9378529483169313.ToString("F0")%
Common Shares in OMER Over Time
Shares Held
Position Value (USD)
Derivatives in OMER
reported options exposure · as of Dec 31, 2025CallValue
$10,308,000
CallShares
600,000
PutValue
$5,504,472
PutShares
320,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF MONTREAL /CAN/ holds $580,215,891 across 80 Biotechnology names. OMER ranks #14 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
390,476 | $174,363,150 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,055,597 | $68,223,231 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
85,524 | $66,079,260 | |
| 4 | ARGX |
Argenx SE
|
85,333 | $62,314,421 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
239,265 | $45,233,045 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
86,183 | $17,206,434 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
515,328 | $17,119,195 | |
| 8 | INCY |
Incyte Corp
|
171,790 | $16,168,871 |
All Filings in OMER
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,002,578 | 568,426 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $10,336,226 | 601,643 | Shares | Defined | 2026-02-12 | |
| 2025-12-31 | $10,308,000 | 600,000 | Call | Defined | 2026-02-12 | |
| 2025-12-31 | $5,504,472 | 320,400 | Put | Defined | 2026-02-12 | |
| 2025-09-30 | $2,308,689 | 563,095 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,713,285 | 571,095 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $4,628,640 | 563,095 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $5,563,378 | 563,095 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,235,491 | 563,096 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,286,169 | 563,096 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,942,681 | 563,096 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,841,323 | 563,096 | Shares | Defined | 2024-02-08 | |
| 2023-09-30 | $1,644,826 | 563,297 | Shares | Defined | 2023-11-01 | |
| 2023-06-30 | $3,064,335 | 563,297 | Shares | Defined | 2023-08-02 | |
| 2023-03-31 | $2,618,391 | 563,095 | Shares | Defined | 2024-06-13 | |
| 2022-12-31 | $1,272,594 | 563,095 | Shares | Defined | 2023-02-01 | |
| 2022-09-30 | $1,773,749 | 563,095 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $1,548,511 | 563,095 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $3,681,828 | 612,617 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $3,658,637 | 568,995 | Shares | Defined | 2022-02-11 | |
| 2021-12-31 | $64,300 | 10,000 | Put | Defined | 2022-02-11 | |
| 2021-09-30 | $9,297,465 | 674,218 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $9,618,293 | 648,133 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $10,519,389 | 590,977 | Shares | Defined | 2021-05-13 | |
| 2021-03-31 | $400,500 | 22,500 | Put | Defined | 2021-05-13 | |
| 2021-03-31 | $5,019,600 | 282,000 | Call | Defined | 2021-05-13 | |
| 2020-12-31 | $6,952,498 | 486,529 | Shares | Defined | 2021-02-12 | |
| 2020-12-31 | $3,312,422 | 231,800 | Call | Defined | 2021-02-12 | |
| 2020-09-30 | $6,943,678 | 686,813 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $2,123,124 | 144,234 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $1,030,612 | 77,084 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||